237 related articles for article (PubMed ID: 14752241)
41. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
[TBL] [Abstract][Full Text] [Related]
42. Up-regulation of connexin43 in glomerular podocytes in response to injury.
Yaoita E; Yao J; Yoshida Y; Morioka T; Nameta M; Takata T; Kamiie J; Fujinaka H; Oite T; Yamamoto T
Am J Pathol; 2002 Nov; 161(5):1597-606. PubMed ID: 12414508
[TBL] [Abstract][Full Text] [Related]
43. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
Floege J; Kriz W; Schulze M; Susani M; Kerjaschki D; Mooney A; Couser WG; Koch KM
J Clin Invest; 1995 Dec; 96(6):2809-19. PubMed ID: 8675651
[TBL] [Abstract][Full Text] [Related]
44. GIV/girdin links vascular endothelial growth factor signaling to Akt survival signaling in podocytes independent of nephrin.
Wang H; Misaki T; Taupin V; Eguchi A; Ghosh P; Farquhar MG
J Am Soc Nephrol; 2015 Feb; 26(2):314-27. PubMed ID: 25012178
[TBL] [Abstract][Full Text] [Related]
45. Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction.
Ko HT; Yin JL; Wyburn K; Wu H; Eris JM; Hambly BD; Chadban SJ
Nephrol Dial Transplant; 2013 Feb; 28(2):327-36. PubMed ID: 23229928
[TBL] [Abstract][Full Text] [Related]
46. Effects of VEGF/VEGFR/K-ras signaling pathways on miRNA21 levels in hepatocellular carcinoma tissues in rats.
Gao JZ; Wang YL; Li J; Wei LX
Genet Mol Res; 2015 Jan; 14(1):671-9. PubMed ID: 25730004
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis.
Khong TF; Fraser S; Katerelos M; Paizis K; Hill PA; Power DA
Kidney Int; 2000 Sep; 58(3):1098-107. PubMed ID: 10972674
[TBL] [Abstract][Full Text] [Related]
48. Immunoelectron microscopic study on type I, II and III TGF-beta receptors on visceral glomerular epithelial cells in relation to glomerular basement membrane alterations in proteinuric rats.
Fujigaki Y; Watanabe T; Ikegaya N; Yonemura K; Sun DF; Hishida A; Yamamoto T; Kojima K; Nagase M
Nephrol Dial Transplant; 2000 Feb; 15(2):191-9. PubMed ID: 10648664
[TBL] [Abstract][Full Text] [Related]
49. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
[TBL] [Abstract][Full Text] [Related]
50. Expression of the chemokine fractalkine (FKN/CX3CL1) by podocytes in normal and proteinuric rat kidney glomerulus.
Katsuyama K; Fujinaka H; Yamamoto K; Nameta M; Yaoita E; Yoshida Y; Tomizawa S; Uchiyama M; Yamamoto T
Nephron Exp Nephrol; 2009; 113(2):e45-56. PubMed ID: 19590241
[TBL] [Abstract][Full Text] [Related]
51. Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.
Tofovic SP; Rominski BR; Bastacky S; Jackso EK; Kost CK
Ren Fail; 2000 Mar; 22(2):159-79. PubMed ID: 10803761
[TBL] [Abstract][Full Text] [Related]
52. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Fukuda A; Fujimoto S; Iwatsubo S; Kawachi H; Kitamura K
Nephrology (Carlton); 2010 Apr; 15(3):321-6. PubMed ID: 20470301
[TBL] [Abstract][Full Text] [Related]
53. Novel expression of sodium/myo-inositol co-transporter in podocytes in puromycin aminonucleoside nephrosis.
Watanabe Y; Kobayashi T; Yaoita E; Kawachi H; Yamauchi A; Inoue T; Shimizu F; Yoshida Y; El-Shemi AG; Okada H; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Apr; 19(4):817-22. PubMed ID: 15031335
[TBL] [Abstract][Full Text] [Related]
54. Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis.
Nakamura T; Ebihara I; Fukui M; Osada S; Nagaoka I; Horikoshi S; Tomino Y; Koide H
Clin Immunol Immunopathol; 1993 Jan; 66(1):33-42. PubMed ID: 8095004
[TBL] [Abstract][Full Text] [Related]
55. Role of smooth muscle protein SM22α in glomerular epithelial cell injury.
Marshall CB; Krofft RD; Blonski MJ; Kowalewska J; Logar CM; Pippin JW; Kim F; Feil R; Alpers CE; Shankland SJ
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F1026-42. PubMed ID: 21289056
[TBL] [Abstract][Full Text] [Related]
56. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
[TBL] [Abstract][Full Text] [Related]
57. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.
Neale TJ; Ojha PP; Exner M; Poczewski H; Rüger B; Witztum JL; Davis P; Kerjaschki D
J Clin Invest; 1994 Oct; 94(4):1577-84. PubMed ID: 7929834
[TBL] [Abstract][Full Text] [Related]
58. Differential nephron HO-1 expression following glomerular epithelial cell injury.
Datta PK; Reddy S; Sharma M; Lianos EA
Nephron Exp Nephrol; 2006; 103(4):e131-8. PubMed ID: 16601358
[TBL] [Abstract][Full Text] [Related]
59. Modulation of basement membrane component gene expression in glomeruli of aminonucleoside nephrosis.
Nakamura T; Ebihara I; Shirato I; Tomino Y; Koide H
Lab Invest; 1991 May; 64(5):640-7. PubMed ID: 2030578
[TBL] [Abstract][Full Text] [Related]
60. Expression of Cathepsin L and Its Intrinsic Inhibitors in Glomeruli of Rats With Puromycin Aminonucleoside Nephrosis.
Kubo A; Shirato I; Hidaka T; Takagi M; Sasaki Y; Asanuma K; Ishidoh K; Suzuki Y
J Histochem Cytochem; 2018 Dec; 66(12):863-877. PubMed ID: 30052474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
